Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1975-07-17
1977-04-05
Tanenholtz, Alvin E.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
195 96, 260112R, A61K 3574, A61K 3702, C12D 920
Patent
active
040162605
ABSTRACT:
A novel polypeptide designated as Gamba A having anti-tumor activity, is produced by cultivating a variant strain of Pseudomonas cruciviae, i.e., Pseudomonas sp. No. 2205 (FERM-P 2132 ATCC 31155), and recovering the polypeptide from the cultured broth thereof.
REFERENCES:
patent: 3705237 (1972-12-01), Grandpierre et al.
Chemical Abstracts, vol. 70, 7646v, (1969).
Chemical Abstracts, vol. 74, 95360g, (1971).
Chemical Abstracts, vol. 75, 4023f, (1971).
Furuichi Etsuko
Hayashi Chikako
Karasaki Tadashi
Tanenholtz Alvin E.
Toyama Chemical Co., Ltd.
LandOfFree
Novel polypeptide produced by pseudomonas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel polypeptide produced by pseudomonas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel polypeptide produced by pseudomonas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2266230